Cytek Biosciences (CTKB) Short Interest Ratio & Short Volume → The #1 Investment of the Decade… (From Porter & Company) (Ad) Free CTKB Stock Alerts $6.18 -0.12 (-1.90%) (As of 05/13/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Cytek Biosciences Short Interest DataCurrent Short Volume7,850,000 sharesPrevious Short Volume7,470,000 sharesChange Vs. Previous Month+5.09%Dollar Volume Sold Short$47.18 millionShort Interest Ratio / Days to Cover11.2Last Record DateApril 30, 2024Outstanding Shares131,270,000 sharesFloat Size119,190,000 sharesShort Percent of Float6.59%Today's Trading Volume1,243,088 sharesAverage Trading Volume730,215 sharesToday's Volume Vs. Average170% Short Selling Cytek Biosciences ? Sign up to receive the latest short interest report for Cytek Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCTKB Short Interest Over TimeCTKB Days to Cover Over TimeCTKB Percentage of Float Shorted Over Time Ad Porter & CompanyAmerica’s worst nightmare?What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.Click here to watch this bombshell exposé now. Cytek Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20247,850,000 shares $47.18 million +5.1%6.6%11.2 $6.01 4/15/20247,470,000 shares $44.97 million -24.9%6.3%10.8 $6.02 3/31/20249,950,000 shares $66.76 million +16.9%8.4%13.8 $6.71 3/15/20248,510,000 shares $59.14 million +9.2%7.1%11.6 $6.95 2/29/20247,790,000 shares $59.98 million +4.6%6.3%10.2 $7.70 2/15/20247,450,000 shares $64.96 million -2.5%6.3%9.1 $8.72 Get the Latest News and Ratings for CTKB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cytek Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/20247,640,000 shares $57.68 million No Change6.6%8.1 $7.55 1/15/20247,640,000 shares $62.72 million +5.2%6.6%7.1 $8.21 12/31/20237,260,000 shares $66.21 million -5.2%6.3%6.5 $9.12 12/15/20237,660,000 shares $69.55 million -3.8%6.6%7.1 $9.08 11/30/20237,960,000 shares $55.24 million -5.0%6.9%7.2 $6.94 11/15/20238,380,000 shares $47.85 million +5.8%7.2%7.8 $5.71 10/31/20237,920,000 shares $33.34 million +0.6%6.8%8.1 $4.21 10/15/20237,870,000 shares $39.51 million -2.8%6.7%8.9 $5.02 9/30/20238,100,000 shares $44.71 million -31.8%6.9%9.5 $5.52 9/15/202311,880,000 shares $83.16 million +0.5%10.4%14.2 $7.00 8/31/202311,820,000 shares $89.83 million +2.7%10.3%14.8 $7.60 8/15/202311,510,000 shares $100.25 million -4.2%10.1%15.2 $8.71 7/31/202312,020,000 shares $107.70 million +4.9%11.0%12.3 $8.96 7/15/202311,460,000 shares $103.25 million +9.4%10.5%8.3 $9.01 6/30/202310,480,000 shares $89.50 million +11.4%9.6%7.6 $8.54 6/15/20239,410,000 shares $81.68 million +8.4%8.6%6.8 $8.68 5/31/20238,680,000 shares $67.79 million -22.6%8.0%6.5 $7.81 5/15/202311,210,000 shares $81.61 million +66.1%10.3%8.3 $7.28 4/30/20236,750,000 shares $77.49 million +3.7%7.2%6.2 $11.48 4/15/20236,510,000 shares $66.27 million +15.2%6.0%9.6 $10.18 3/31/20235,650,000 shares $51.92 million -2.4%5.2%8.2 $9.19 3/15/20235,790,000 shares $56.16 million +1.1%5.3%8.3 $9.70 2/28/20235,730,000 shares $59.02 million +4.4%5.3%8.8 $10.30 2/15/20235,490,000 shares $65.50 million +7.7%5.2%8.8 $11.93 1/31/20235,100,000 shares $61.46 million +28.5%5.6%8.3 $12.05 1/15/20233,970,000 shares $43.63 million +9.7%4.3%6.6 $10.99 12/30/20223,620,000 shares $36.96 million +4.3%4.3%6.5 $10.21 12/15/20223,470,000 shares $37.44 million +20.9%4.1%5.9 $10.79 11/30/20222,870,000 shares $36.99 million +3.6%3.4%4.4 $12.89 11/15/20222,770,000 shares $40.86 million -14.8%3.3%4.1 $14.75 10/31/20223,250,000 shares $50.44 million -13.8%4.4%4.8 $15.52 10/15/20223,770,000 shares $54.25 million -9.4%5.0%5.6 $14.39 9/30/20224,160,000 shares $61.24 million +51.3%5.6%6.2 $14.72 9/15/20222,750,000 shares $38.20 million +3.8%3.7%4 $13.89The #1 Investment of the Decade… (Ad)Sam Altman, the CEO of OpenAI, has invested $375 million into a breakthrough technology, that legendary financial analyst Porter Stansberry believes… …could be the number-one investment of the decade.To get all the details of this controversial tech – click here now. CTKB Short Interest - Frequently Asked Questions What is Cytek Biosciences' current short interest? Short interest is the volume of Cytek Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 7,850,000 shares of CTKB short. 6.59% of Cytek Biosciences' shares are currently sold short. Learn More on Cytek Biosciences' current short interest. What is a good short interest ratio for Cytek Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CTKB shares currently have a short interest ratio of 11.0. Learn More on Cytek Biosciences's short interest ratio. Which institutional investors are shorting Cytek Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cytek Biosciences: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Cytek Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.59% of Cytek Biosciences' floating shares are currently sold short. Is Cytek Biosciences' short interest increasing or decreasing? Cytek Biosciences saw a increase in short interest in April. As of April 30th, there was short interest totaling 7,850,000 shares, an increase of 5.1% from the previous total of 7,470,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cytek Biosciences' float size? Cytek Biosciences currently has issued a total of 131,270,000 shares. Some of Cytek Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cytek Biosciences currently has a public float of 119,190,000 shares. How does Cytek Biosciences' short interest compare to its competitors? 6.59% of Cytek Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Cytek Biosciences: Standard BioTools Inc. (3.09%), Quanterix Co. (3.84%), EyePoint Pharmaceuticals, Inc. (12.67%), Valneva SE (0.08%), Pacific Biosciences of California, Inc. (19.39%), Allogene Therapeutics, Inc. (32.03%), Prothena Co. plc (12.55%), Nautilus Biotechnology, Inc. (1.96%), Myriad Genetics, Inc. (6.57%), Olink Holding AB (publ) (1.99%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Cytek Biosciences stock? Short selling CTKB is an investing strategy that aims to generate trading profit from Cytek Biosciences as its price is falling. CTKB shares are trading down $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cytek Biosciences? A short squeeze for Cytek Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CTKB, which in turn drives the price of the stock up even further. How often is Cytek Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CTKB, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Standard BioTools Short Interest Quanterix Short Interest EyePoint Pharmaceuticals Short Interest Valneva Short Interest Pacific Biosciences of California Short Interest Allogene Therapeutics Short Interest Prothena Short Interest Nautilus Biotechnology Short Interest Myriad Genetics Short Interest Olink Holding AB (publ) Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CTKB) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldElon to Transform U.S. Economy? Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders